Synlett
DOI: 10.1055/a-2320-6127
letter

One-Pot and Three-Component Coupling Synthesis of Novel p-[(Benzothiazolylamino)(aryl/heteroaryl)methyl]phenols and Its Corresponding O-Tosylates under Catalyst- and Solvent-Free Conditions

a   Department of Chemistry, Faculty of Science, Umm Al-Qura University, Makkah 21955, Saudi Arabia
,
Mustafa S. Alluhaibi
a   Department of Chemistry, Faculty of Science, Umm Al-Qura University, Makkah 21955, Saudi Arabia
,
Narasimhulu Gandhamsetty
b   Research & Development Center, Department of Chemistry, LNC Pharmarix, Sangareddy, Hyderabad, Telangana, India – 502307, India
› Author Affiliations
M. B. Hawsawi and M. S. Alluhaibi are grateful to Umm Al-Qura University, Makkah 21955, Saudi Arabia for continuous support for this work. N.G. is thankful for financial assistance from LNC PHARMARIX, Hyderabad, India.


Abstract

A catalyst- and solvent-free procedure has been developed for the synthesis of p-[( benzothiazolylamino)(aryl/heteroaryl)methyl]-functionalized phenols and its O-tosylates via one-pot three-component coupling reaction of thymol or carvacrol, aryl/heteroaryl aldehydes, and 2-aminobenzothiazoles with high selectivity. The present amino methylation process is convenient to perform even on large scale with a broad scope. The products were likely formed through the initial para attack of thymol on aldehydes to generate p-quinone methide intermediate and subsequent 1,6-aza-Michael addition of 2-aminobenzothiazoles on in-situ generated p-quinone methide intermediate.

Supporting Information



Publication History

Received: 31 March 2024

Accepted after revision: 06 May 2024

Accepted Manuscript online:
06 May 2024

Article published online:
17 May 2024

© 2024. Thieme. All rights reserved

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References and Notes

    • 1a Duggan PJ, Lewis RJ, Lok YP, Lumsden NG, Tuck KL, Yang A. Bioorg. Med. Chem. Lett. 2009; 19: 2763
    • 1b Pilania M, Velladurai A, Tantak MP, Kumar D. ChemistrySelect 2016; 1: 6368
    • 1c Sairaman A, Cardoso FC, Bispat A, Lewis RJ, Duggan PJ, Tuck KL. Bioorg. Med. Chem. 2018; 26: 3046
    • 1d García-Báez EV, Padilla-Martínez II, Tamay-Cach F, Cruz A. Molecules 2021; 26: 6518
    • 1e Uremis N, Uremis MM, Tolun FI, Ceylan M, Doganer A, Kurt AH. Anticancer Res. 2017; 37: 6381
    • 1f Kemisetti D, Amin R, Alam F, Gacem A, Emran TB, Alsufyani T, Alqahtani MS, Islam S, Matin MM, Jameel M. Evidence-Based Complementary Altern. Med. 2023, 5460563, DOI: DOI: 10.1155/2023/5460563.
    • 1g Singh M, Singh SK, Gangwar M, Nath G, Singh SK. RSC Adv. 2014; 4: 19013
    • 2a Baell JB, Duggan PJ, Forsyth SA, Lewis RJ, Lok YP, Schroeder CI. Bioorg. Med. Chem. 2004; 12: 4025
    • 2b Bondock S, Fadaly W, Metwally MA. J. Sulfur Chem. 2009; 30: 74
    • 2c Zhilitskaya LV, Yarosh NO. Chem. Heterocycl. Compd. 2021; 57: 369
    • 2d Tulshiram L, Dadmal TL, Katre SD, Mandewale MC, Kumbhare RM. New J. Chem. 2018; 42: 776
    • 3a Beena Beena, Kumar D, Rawat DS. Bioorg. Med. Chem. Lett. 2013; 23: 641 ; and related references are here
    • 3b Nagle PS, Pawar YA, Sonawane AE, Bhosale SM, More DH. Med. Chem. Res. 2012; 21: 1395
    • 4a Sakarya HC, Gӧrgün K, Öǧretir C. Arab. J. Chem. 2016; 9: S1314
    • 4b Yan D, Wu X, Xiao J, Zhu Z, Xu X, Bao X, Yao Y, Shen Q, Xue M. Org. Chem. Front. 2019; 6: 648
    • 4c Kühler TC, Swanson M, Christenson B, Klintenberg AC, Lamm B, Fägerhag J, Gatti R, Ölwegård-Halvarsson M, Shcherbuchin V, Elebring T, Sjöström JE. J. Med. Chem. 2002; 45: 4282
  • 5 Yangbo F, Philip L.-G, Thomas S, Yan Y. WO2010024903, 2010
    • 6a Eshghi H, Bakavoli M, Abedini-Torghabeh J, Rahimizadeh M. Chin. Chem. Lett. 2012; 23: 1153
    • 6b Anand N, Ramakrishna KK. G, Gupt MP, Chaturvedi V, Singh S, Srivastava KK, Sharma P, Rai N, Ramachandran R, Dwivedi AK, Gupta V, Kumar B, Pandey S, Shukla PK, Pandey SK, Lal J, Tripathi RP. ACS Med. Chem. Lett. 2013; 4: 958
    • 6c Singh A, Gupta S, Khurana JM. Org. Prep. Proced. Int. 2020; 52: 110
    • 6d Oda R, Nakata K. Eur. J. Org. Chem. 2021; 295
    • 7a Betti M. Gazz. Chim. Ital. 1900; 30: 301

    • For reviews, see:
    • 7b Olyaei A, Sadeghpour M. RSC Adv. 2019; 9: 18467
    • 7c Iftikhar R, Kamran M, Iftikhar A, Parveen S, Naeem N, Jamil N. Mol. Diversity 2022; 27: 543
    • 8a Karami B, Farahi M, Farmani N, Tanuraghaj HM. New J. Chem. 2016; 40: 1715
    • 8b Khandarkar KM, Shanti MD, Ahmed M, Meshram JS. J. Chem. Sci. 2013; 125: 1573
    • 8c Emmadi NR, Atmakur K, Chennapuram M, Nanubolu JB. RSC Adv. 2014; 4: 14501
    • 9a Kantevari S, Yempala T, Vuppalapati SV. N. Synthesis 2010; 959
    • 9b Kantevari S, Yempala T, Yogeeswari P, Sriram D, Sridhar B. Bioorg. Med. Chem. Lett. 2011; 21: 4316
  • 10 Cherkadu V, Kalavagunta PK, Ningegowda M, Shivananju NS, Madegowda M, Priya BS. Synlett 2016; 27: 1116
    • 11a Olyaei A, Zarnegar M, Sadeghpour M, Rezaei M. Lett. Org. Chem. 2012; 9: 451
    • 11b Sahu PK, Praveen K, Sahuab PK, Dau D, Agarwal DD. RSC Adv. 2014; 4: 40414
    • 11c Jonnala S, Nameta B, Chavali M, Bantu R, Choudante P, Misra S, Sridhar B, Dilip S, Reddy BV. S. Lett. Org. Chem. 2019; 16: 837
    • 11d Taghrir H, Ghashang M, Biregan MN. Chin. Chem. Lett. 2016; 27: 119
    • 11e Moosavi-Zare AR, Zolfigol MA, Daraei M. Synlett 2014; 25: 1173
  • 12 Olyaei A, Rahmani N, Sadeghpour M, Mohamadi A. Lett. Org. Chem. 2022; 19: 333
    • 13a Shaabani A, Rahmati A, Farhangi E. Tetrahedron Lett. 2007; 48: 7291
    • 13b Serrao E, Debnath B, Otake H, Kuang Y, Christ F, Debyser Z, Neamati N. J. Med. Chem. 2013; 56: 2311
    • 14a Jurd L. J. Heterocycl. Chem. 1997; 34: 601
    • 14b Barroso S, Abreu AM, Araújo AC, Coelho AM, Maulide N, Martins AM. Synlett 2010; 2425
    • 14c Jameel AA, Padusha MS. A. Asian J. Chem. 2010; 22: 3422
    • 14d Mulla SA. R, Salama TA, Pathan MY, Inamdar SM, Chavan SS. Tetrahedron Lett. 2013; 54: 672
    • 14e Salgado-Escobar O, Chavelas-Hernández L, Domínguez-Mendoza BE, Linzaga-Elizalde I, Ordoñez M. Molecules 2015; 20: 13794
    • 14f Shushizadeh MR, Azizyan S. Jundishapur J. Nat. Pharm Prod. 2014; 9: e17808
    • 14g Cherkadu V, Kalavagunta PK, Ravirala N, Shivananju NS, Priya BS. Synlett 2016; 27: 2795
  • 15 Enache TA, Oliveira-Brett AM. J. Electroanal. Chem. 2011; 655: 9 ; and related references are here
  • 16 Baier DM, Rensch T, Bergheim K, Pietryga V, Grätz S, Borchardt L. Chem. Eur. J. 2023; 29: e202203931
    • 18a Multicomponent Reactions . Zhu J, Bienaymé H. Wiley–VCH; Weinheim: 2005
    • 18b Orru RV. A, Greef DM. Synthesis 2003; 1471
    • 18c Ugi I, Heck S. Comb. Chem. High Throughput Screening 2001; 4: 1
    • 18d Hagan DO. Nat. Prod. Rep. 2000; 17: 435
    • 18e Claudio-Catalán MA, Pharande SG, Quezada-Soto A, Kishore KG, Rentería-Gómez A, Padilla-Vaca F, Gámez-Montaño R. ACS Omega 2018; 3: 5177
    • 18f Santra S, Rahman M, Roy A, Majee A, Hajra A. Org. Chem. Int. 2014; 851924 DOI: 10.1155/2014/851924.
    • 18g Zhao JL, Liu L, Zhang HB, Wu YC, Wang D, Chen YJ. Synlett 2006;  96
    • 18h Malviya BK, Singh K, Jaiswal PK, Shukla M, Verma VP, Vanangamudi M, Jassal AK, Punjabi PB, Sharma S. ACS Omega 2019; 4: 12146
    • 18i Kumar KP, Satyanarayana S, Reddy PL, Narasimhulu G, Ravirala N, Reddy BV. S. Tetrahedron Lett. 2012; 53: 1738
    • 19a Lima CG. S, Pauli FP, Costa DC. S, Souza AS. D, Forezi LS. M, Ferreira VF, Silva FD. C. Eur. J. Org. Chem. 2020; 2650
    • 19b Wang JY, Hao WJ, Tu SJ, Jianga B. Org. Chem. Front. 2020; 7: 1743
    • 19c Dash R, Hota SK, Murarka S. Synthesis 2024; 56: 677
    • 20a Zhoua T, Szostak M. Catal. Sci. Technol. 2020; 10: 5702
    • 20b Roy AH, Hartwig JF. Organometallics 2004; 23: 194
    • 20c Dhonthulachitty C, Kothakapu SR, Neella CK. Tetrahedron Lett. 2016; 57: 4620
    • 20d Wuts PG. M, Greene TW. Greene’s Protective Groups in Organic Synthesis, 4th ed. . John Wiley & Sons; Hoboken: 2007
    • 21a Lasne MC, Ripoll JL, Denis JM. Tetrahedron 1981; 37: 503
    • 21b Udayakumar S, Ajaikumar S, Pandurangan A. Catal. Commun. 2007; 8: 366
  • 22 General Procedure 1: Synthesis of 4-[(Benzo[d]thiazol-2-ylamino)(phenyl)methyl]-2-isopropyl-5-methylphenol Derivatives (Table 2 and Scheme 3) To a 10 mL round-bottomed flask aldehyde (2.2 mmol), powdered thymol or carvacrol (2.0 mmol), and benzo[d]thiazol-2-amines (2.0 mmol) were added and mixed thoroughly at 20–30 °C under nitrogen atmosphere and the resulting reaction mass was introduced to the preheated oil bath at 150–160 °C for the appropriate time (Tables 2 and Scheme 3). After completion of the reaction as indicated by TLC (30% ethyl acetate in hexanes), the reaction mixture was allowed to cool. The solid mass was dissolved in ethyl acetate, concentrated, and purified by silica gel (Merck, 60–120 mesh) column chromatography with ethyl acetate/hexanes (3:7) to obtain the corresponding pure p-[( benzothiazolylamino)(aryl/heteroaryl)methyl]phenols 4a–j (Table 2 and Scheme 3). General Procedure 2: Gram-Scale Synthesis for Compounds 4d and 4g – Synthesis of 4-[(Benzo[d]thiazol-2-ylamino)(phenyl)methyl]-2-isopropyl-5-methylphenol Derivatives To a 50 mL round-bottomed flask aldehyde (5.5 mmol), powdered thymol (5.0 mmol), and benzo[d]thiazol-2-amines (5.0 mmol) were added and mixed thoroughly at 20–30 °C under nitrogen atmosphere, and the resulting reaction mass was introduced to the preheated oil bath at 150–160 °C for the appropriate time (Table 2). After completion of the reaction as indicated by TLC (30% ethyl acetate in hexanes), the reaction mixture was allowed to cool. The solid mass was dissolved in ethyl acetate, concentrated under reduced pressure, and crystalized with isopropyl alcohol (2 × 10 mL) to obtain the corresponding pure p-[(benzothiazolylamino)(aryl/heteroaryl)methyl]phenols 4b and 4e (Table 2). General Procedure 3 (Table 3, 5a-f) (i) To a 10 mL round-bottomed flask aldehyde (2.2 mmol), powdered thymol (2.0 mmol), and benzo[d]thiazol-2-amines (2.0 mmol) were added and mixed thoroughly at 20–30 °C under nitrogen atmosphere, and the resulting reaction mass was introduced to the preheated oil bath at 150–160 °C for the appropriate time (Table 3). After completion of the reaction as indicated by TLC (30% ethyl acetate in hexanes), the reaction mixture was allowed to cool. The solid mass was dissolved in ethyl acetate and concentrated under reduced pressure to dryness. The obtained residue was washed with ethyl acetate/hexanes (5:95) to obtain the crude products 5a′f′ (Table 3). The resulting residue was subjected to O-sulfonylation. (ii) The above crude mixture was diluted with anhydrous dichloromethane (6 mL) and cooled down to 0–5 °C. Then, p-toluenesulfonyl chloride (3.0 mmol, 1.5 equiv) was slowly added portionwise into the above reaction mixture in the presence of excessive triethylamine (6.0 mmol, 3.0 equiv) and a catalytic amount of 4-dimethylaminopyridine (0.02 mmol, 1 mol%) at 0 °C. Then, the resulting reaction mixture was allowed to react at room temperature. After 4 h, the reaction mixture was quenched by adding water (15 mL), and the reaction mixture was extracted with dichloromethane (2 × 15 mL). The combined dichloromethane organic layers were dried over Na2SO4, concentrated under vacuum, and purified by column chromatography on silica gel (ethyl acetate/hexanes = 3/7) to give the corresponding O-tosylated p-[( benzothiazolylamino) (aryl) methyl]phenols 5af.